Food and Drug Administration
Pulmonary-Allergy Drugs Advisory Committee
Holiday Inn,
Meeting Roster
Acting
Chairman
Polly
E. Parsons, M.D.
Executive
Secretary
Kimberly
Littleton Topper, M.S.
MEMBERS
Talmadge E. King, Jr., M.D.
Peter
E. Morris, M.D., FACP, FCCP
Consumer
Representative
Karen
Schell, RRT
Voting Special Government Employees
Andrea
J. Apter, M.D., M.S.C.
Pulmonary,
Allergy and
Critical
Care Division
829
Hospital
of the
Carroll
Cross, M.D.
Pulmonary-Critical
Medicine
Jesse
Joad, M.D.
Department
of Pediatrics
Carolyn M.
Kercsmar, M.D.
Rainbow Babies
and
Children’s
Hospital
Dept. of
Pediatrics
Lee S. Newman, M.D., M.A.,
F.C.C.P.
National Jewish Medical
and
Department of Medicine
Division of Environmental and
Occupational Health Sciences
Christina M. Surawicz, M.D
Professor
of Medicine
Non-Voting Industry Representative
William
Kennedy
Food and Drug Administration
Pulmonary-Allergy Drugs Advisory Committee
Holiday Inn,
Meeting Roster
FDA STAFF
Raymond F. Anthracite, M.D.
Medical Officer
Center for Drug Evaluation
and Research
Office of Drug Evaluation II
Division of Pulmonary and
Allergy Drug Products
Badrul Chowdhury, M.D.
Division Director
Center for Drug Evaluation
and Research
Office of Drug Evaluation II
Division of Pulmonary and
Allergy Drug Products
James Gebert, Ph.D.
Statistician
Center for Drug Evaluation
and Research
Office of Biostatistics
Division of Biometrics II
Robert Meyer, M.D.
Director
Center for Drug Evaluation
and Research
Office of Drug Evaluation II
Sandra Suarez-Sharp, Ph.D.
Clinical Pharmacologist
Center for Drug Evaluation
and Research
Office of Pharmaceutical
Science
Office of Clinical
Pharmacology and Biopharmaceutics
Virgil Whitehurst, Ph.D.
Pharmacologist
Center for Drug Evaluation
and Research
Office of Drug Evaluation II
Division of Pulmonary and
Allergy Drug Products